https://biotechmorning.com/news/ai-designed-lung-drug-rentosertib-ipf-phase-2a Biotech Morning en 2026-06-25T14:28:42.428Z The Robot That Designed a Lung Drug (and It Actually Worked) https://biotechmorning.com/news/fda-ngs-genome-editing-off-target-guidance Biotech Morning en 2026-06-25T14:27:52.585Z The FDA Just Told CRISPR Companies Exactly How to Prove Their Edits Are Safe https://biotechmorning.com/news/one-shot-to-silence-disease-forever-intellia-crispr Biotech Morning en 2026-06-25T14:26:59.430Z One Shot to Silence a Disease Forever https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition-11-billion Biotech Morning en 2026-06-25T14:26:01.236Z Merck KGaA Just Dropped $11 Billion on a Company Most People Never Heard Of https://biotechmorning.com/news/ibrance-hER2-positive-breast-cancer-maintenance-approval Biotech Morning en 2026-06-25T14:25:05.164Z Ibrance Just Crossed a Line Nobody Thought It Could https://biotechmorning.com/news/nipocalimab-waiha-first-approved-treatment Biotech Morning en 2026-06-25T14:24:13.981Z The Blood Disease Nobody Could Treat Just Got Its First Real Shot https://biotechmorning.com/news/biosecure-act-china-biotech-expansion Biotech Morning en 2026-06-25T14:23:25.976Z The $6 Billion Wall That China's Biotech Giants Keep Walking Through https://biotechmorning.com/news/alzpath-abbott-alzheimer-blood-test-deal Biotech Morning en 2026-06-25T14:22:29.974Z The $17 Blood Test That Could Rewrite Alzheimer's Diagnosis https://biotechmorning.com/news/pfizer-berobenatide-monthly-glp1-phase-2b Biotech Morning en 2026-06-25T14:21:42.476Z Pfizer Just Made the GLP-1 Shot a Once-a-Month Thing https://biotechmorning.com/news/trodelvy-first-line-tnbc-fda-approval Biotech Morning en 2026-06-25T14:20:43.430Z Trodelvy Just Jumped the Line in Breast Cancer Treatment https://biotechmorning.com/news/pig-kidney-271-days-fda-expansion Biotech Morning en 2026-06-25T14:19:53.694Z A Pig Kidney Kept a Man Alive for 271 Days. Now the FDA Wants More. https://biotechmorning.com/news/eli-lilly-cuts-off-hospitals-340b-discounts Biotech Morning en 2026-06-24T14:25:25.078Z Eli Lilly Just Cut Off 50 Hospital Systems. The Reason Will Surprise You. https://biotechmorning.com/news/sangamo-gene-editing-pioneer-sold-for-parts Biotech Morning en 2026-06-24T14:24:37.621Z Gene Editing's Original Pioneer Just Got Sold for Parts https://biotechmorning.com/news/biogen-apellis-acquisition-complement-platform Biotech Morning en 2026-06-24T14:23:50.396Z Biogen Just Spent $5.6 Billion on a Comeback Story https://biotechmorning.com/news/china-car-t-solid-tumor-approval Biotech Morning en 2026-06-24T14:22:58.756Z China Just Cracked the Code That CAR-T Couldn't https://biotechmorning.com/news/jnj-firefly-bio-billion-dollar-acquisition Biotech Morning en 2026-06-24T14:22:07.024Z J&J Just Paid $1 Billion for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/serapha-bio-230m-series-a-gene-editing-china Biotech Morning en 2026-06-24T14:21:14.459Z A $230M Bet on a Gene Editor Born in China https://biotechmorning.com/news/ollin-330m-bet-dethrone-roche-eye-drug Biotech Morning en 2026-06-24T14:20:18.151Z The $330M Bet to Dethrone Roche's Eye Drug Empire https://biotechmorning.com/news/lilly-abbisko-1-9-billion-shanghai-collaboration Biotech Morning en 2026-06-24T14:19:20.196Z Lilly Keeps Going Back to the Same Shanghai Lab. Here's Why. https://biotechmorning.com/news/servier-edgewise-muscular-dystrophy-deal Biotech Morning en 2026-06-24T14:18:29.322Z Servier Just Dropped $2.65 Billion on a Drug That Doesn't Exist Yet https://biotechmorning.com/news/eli-lilly-centessa-sleep-disorders-acquisition Biotech Morning en 2026-06-24T14:17:31.378Z Eli Lilly Just Spent $6.3 Billion to Fix a Problem You Didn't Know It Had https://biotechmorning.com/news/merck-6-7-billion-terns-pharmaceuticals-cml-2 Biotech Morning en 2026-06-24T14:16:35.597Z Merck Just Spent $6.7 Billion on a Drug Most People Have Never Heard Of